(1R,5S)-3-ethyl-Bicyclo[3.2.0]hept -3-en-6-one NEW

Dorra Pharma is a comprehensive pharmaceutical group integrating research and development, production, and sales. Our main product areas include pharmaceutical active ingredients and intermediates, cosmetic raw materials, pet pharmaceutical ingredients, and formulation products. We have established dual R&D centers in Nanjing and Taizhou, where we carry out a full range of work from laboratory research to pilot-scale development. The R&D centers are staffed with nearly 100 full-time researchers, having completed the development of over 300 compounds. We have a leading edge in core technologies such as bromination, enzyme/metal catalysis, nitration, hydrogenation, and continuous flow processes, and hold multiple invention patents. Our production bases in Hubei and Gansu have received certifications from major regulatory bodies both domestically and internationally. At Dorra, we are committed to the mission of "creating more valuable products for life and health," constantly striving for excellence and creating greater value for both our clients and our business!